It has been confirmed that LncRNAs can function as molecular signaling mediators to regulate glioma phenotypes through mediating the expression of genes in NEAT1-WNT/β catenin 27 and CRNDE- mTOR signaling pathway 28. The gene discussed is MTOR; the disease is central nervous system cancer.